drugset / Trial / NCT05553392

StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis

NCT05553392

Terminated 13 enrolled Stratpharma AG
RandomizedParallel-groupSingle-blindPrevention

Summary

The aim of this study is to assess the efficacy and safety of StrataXRT® in comparison to standard of care (defined using the Common Terminology Criteria for Adverse Events \[CTCAE\], version 5.0) by assessing the severity of inguinal RD in patients receiving elective radiation therapy +/- systemic therapy to the bilateral inguinal nodes.

Timeline

Start
2022-11-01
Primary completion
2024-05-30
Completion
2024-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Petrolatum Unknown Topical

Indications